Literature DB >> 29415360

Metformin-induced encephalopathy: the role of thiamine.

Caoimhe McGarvey1, Catherine Franconi1, David Prentice2, Michael Bynevelt3.   

Abstract

A case of metformin encephalopathy is presented in a patient on haemodialysis for end-stage diabetic renal failure. The patient presented with frequent falls and clinical signs of Parkinsonism, on a background of recent anorexia and significant weight loss. Magnetic resonance imaging showed bilateral, symmetrical abnormalities centred on the lentiform nuclei. Metformin was withheld and signs and symptoms quickly resolved. We hypothesise that metformin may cause thiamine deficiency in patients with end-stage renal failure resulting in a specific metabolic encephalopathy.
© 2018 Royal Australasian College of Physicians.

Entities:  

Keywords:  encephalopathy; end-stage renal failure; haemodialysis; metformin; thiamine deficiency

Mesh:

Substances:

Year:  2018        PMID: 29415360     DOI: 10.1111/imj.13693

Source DB:  PubMed          Journal:  Intern Med J        ISSN: 1444-0903            Impact factor:   2.048


  2 in total

1.  Drug-nutrient interactions: discovering prescription drug inhibitors of the thiamine transporter ThTR-2 (SLC19A3).

Authors:  Bianca Vora; Elizabeth A E Green; Natalia Khuri; Frida Ballgren; Marina Sirota; Kathleen M Giacomini
Journal:  Am J Clin Nutr       Date:  2020-01-01       Impact factor: 7.045

2.  Focal brain lactate accumulation in metformin-induced encephalopathy without systemic lactic acidosis: A case report suggesting mitochondrial vulnerability in lentiform fork sign.

Authors:  Akira Hanazono; Yoshiko Takahashi; Yui Sanpei; Sachiko Kamada; Masashiro Sugawara
Journal:  eNeurologicalSci       Date:  2021-11-29
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.